CERO

CERo Therapeutics Holdings, Inc.

OTCHealthcareBiotechnologyUS

USD0.01

-0.00 (-7.69%)

Rating:B-

Company Profile

CEO

Christopher Ehrlich

IPO Date

2021-11-30

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

Market Metrics

Open

$0.01

Prev. Close

$0.01

Day Low

$0.01

Day High

$0.01

52W Low

$0.01

52W High

$26.99

Market Cap

$0.00B

Volume

0.55M

Price Chart

No price data available.

About

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.

https://www.cero.bio

Price Performance

1 Day

-7.69%

5 Days

-50.00%

1 Month

-59.73%

3 Months

-68.42%